The Parkinson’s Foundation has announced the expansion of PD GENEration: Mapping the Future of Parkinson’s Disease, a first-of-its-kind national initiative offering genetic testing and counseling for people with Parkinson’s disease (PD) at no cost.
Biofourmis, a Boston-based global leader in virtual care and digital therapeutics, announced July 29 the company’s BiovitalsHF solution is the first-ever heart failure digital therapeutic to receive a Breakthrough Device designation from the U.S. Food and Drug Administration.
This white paper from Abbott examines a cross-section of the global healthcare system leveraging primary research with 1,400+ respondents including patients, physicians, and administrators.
CVS Health (CVS) and IBM (IBM) say they’ve formed a partnership designed to better predict deteriorating health of the pharmacy giant’s customers through predictive analytics. IBM’s Watson, the computer giant’s […]
BOSTON–(BUSINESS WIRE)–Health Connexions™ announced today a collaborative partnership with Genelle, a genetic wellness company that provides the opportunity for consumers to unlock their potential through Predictive Consumer Genomics and customized […]
While development of personalized medicines has grown since the human genome was first sequenced in 2001, biopharmaceutical sponsors face a number of hurdles that are impeding more rapid market uptake, […]
BOSTON, MA–(Marketwired – May 14, 2015) – While development of personalized medicines has grown since the human genome was first sequenced in 2001, biopharmaceutical sponsors face a number of hurdles […]
No, Personalized Medicine Isn’t Going To Save $600 Billion Over 50 Years By Preventing Heart Disease The hype over personalized medicine has now reached astonishing new heights. In an article published in the Lancet, Victor […]